SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-03-000187
Filing Date
2003-02-03
Accepted
2003-02-03 17:18:02
Documents
3
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS EC, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH, LLCSFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d-valentis.txt SC 13D 59066
4 EXHIBIT 1 ex1_sc13d-valentis.txt EX-99 9079
5 EXHIBIT 4 ex4_sc13d-valentis.txt EX-24 2359
  Complete submission text file 0000950142-03-000187.txt   73206
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 863A MITTEN ROAD BURLINGAME CA 94010
Business Address 863A MITTEN RD BURLINGAME CA 94010 6506971900
VALENTIS INC (Subject) CIK: 0000932352 (see all company filings)

IRS No.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-53479 | Film No.: 03537051
SIC: 2836 Biological Products, (No Diagnostic Substances)